6932 — Endo Lighting Balance Sheet
0.000.00%
- ¥31bn
- ¥29bn
- ¥54bn
- 68
- 87
- 94
- 97
Annual balance sheet for Endo Lighting, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 10,063 | 10,787 | 12,050 | 16,373 | 15,692 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,737 | 7,439 | 8,277 | 10,257 | 11,653 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 28,495 | 33,368 | 35,140 | 39,924 | 43,072 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 15,963 | 16,405 | 16,634 | 16,871 | 18,176 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 50,547 | 55,595 | 57,343 | 62,753 | 67,667 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 14,096 | 16,621 | 15,965 | 15,238 | 14,551 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 27,011 | 27,352 | 25,808 | 24,186 | 23,616 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 23,536 | 28,243 | 31,535 | 38,567 | 44,051 |
Total Liabilities & Shareholders' Equity | 50,547 | 55,595 | 57,343 | 62,753 | 67,667 |
Total Common Shares Outstanding |